Title
Category
Credits
Event date
Cost
Why Do Smart People Make Mistakes? The Answers are Worthy of a Nobel Prize
  • Behavioral health
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Participants in this activity will learn about the system framework theory of decision-making and how System I- and System II-type cognitive processes can best be utilized in the health care setting. The role of heuristics (mental “shortcuts” and rules-of-thumb) will be examined, as well as the types of cognitive biases (inherent and often unconscious systematic errors in thinking) that most commonly result in negative health outcomes. Debiasing strategies to address these negative influences on rational and optimal decision-making that are applicable to the self and the health care team will be explored. 
CMS HEDIS and Stars Pharmacy Overview—Medication Adherence, Statin Use in Patients and More
  • Disease management
  • 2.00 ACPE - Pharmacists
  • 2.00 ACPE - Pharmacy Technicians
  • 2.00 AMA - Physicians
  • 2.00 ANCC - Nurses
  • 2.00 APA - Psychologists
  • 2.00 Attendance - General Attendance
  • 2.00 ASWB - Social Workers
$0.00
Participants in this activity will learn how CMS measures medication adherence, its role in patient qualification status, impact on claims algorithms, and potential caveats of these determinations. Strategies to address common barriers to medication adherence will be discussed, along with best practices that may improve adherence. In addition, the five measures included in the 2021 Medicare Part D star ratings, including those regarding medication adherence for diabetes, hypertension, cholesterol, as well as statin use in persons with diabetes, will be reviewed.
Non-Alcoholic Fatty Liver Disease
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This activity will discuss the prevalence, diagnosis and factors that contribute to the development of non-alcoholic fatty liver disease (NAFLD). Best practices for the treatment of individuals with NAFLD will also be discussed.
New Trends in the Management of Asthma and Chronic Obstructive Pulmonary Disease
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This activity will provide participants with insight into newer approaches that effectively integrate standard interventions into management plans tailored to the individual’s particular symptoms, review the value of pulmonary rehabilitation, and outline the effective evaluation of therapeutic responses.
Advanced Degenerative Joint Disease and Chronic Lower Back Pain: Evidence-Based Approaches to Care
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This activity will provide participants with insight into newer approaches that effectively integrate standard interventions into management plans tailored to the individual’s particular symptoms, review the value of pulmonary rehabilitation, and outline the effective evaluation of therapeutic responses.
What’s Special about Specialty Pharmacy?
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This session examines the cost of development and growth of these pharmaceuticals and details the specific role that specialty pharmacy plays in making these products accessible. The high costs of therapies and patient and medication management are also discussed along with the role and value of drug benefit programs.
New Trends in Cardiology Imaging
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This activity will discuss CCTA as a new trend in cardiology imaging and its role in providing a comprehensive assessment of patients with suspected CAD.
Chronic Kidney Disease, Metabolic and Cardiovascular Disease: Insights into Present and Future Treatment
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity examines current data about chronic kidney disease (CKD), including its health outcomes and relationships with cardiovascular and metabolic disease. Treatment regimens aimed at delaying progression and their outcomes are reviewed, along with current knowledge regarding the pathophysiologic and genetic basis of this disease. Areas of emerging interest in research on potential new treatments targeting the causes of CKD are discussed, including genomic analysis, and their relevance to clinical care.
Transition of Care: Our Patients Are Growing Up
  • Disease management
  • Pediatrics
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity provides a thorough understanding of the recommended health care transition (HCT) components, considerations and goals that should be constant across HCT planning. It discusses the importance of coordinating the efforts of the health care team, adolescent and family to ensure continuity of care, positive health outcomes, and optimal quality of life.
Managing Urinary Incontinence
  • Disease management
  • Older adults
  • Wellness
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 Attendance - General Attendance
$0.00
This activity will highlight the prevalence of UI; provide effective communication and shared decision-making techniques; and discuss how to assess, treat and provide follow-up care for UI including available resources to support care and management.

Pages